5-Methyl-2-oxo-1,3-dioxane-5-carboxylic acid, 98%, 1g

1-tert-Butylpiperidin-4-ol, 95.0%, 250mg

1-Methyl-5-nitro-1H-pyrazole-4-carboxylic acid, 10g

(2,3-Dihydrothieno[3,4-b][1,4]dioxin-2-yl)methanol>97.0%(GC)200mg

3-Ethynylimidazo[1,2-b]pyridazine, 95.0%, 5g

Cyclobutanemethanethiol, 98.0%, 1g

[(2-bromophenyl)methyl](propyl)amine, 95.0%, 2g

[6-(Pyrrolidin-1-yl)-5-(trifluoromethyl)pyridin-3-yl]boronic acid, 98%, 1g

2,3-Dihydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester, 98+%, 100mg

6-Chloroimidazo[1,2-b]pyridazin-8-amine, 95.0%, 500mg

dimethyl sulfoxide, min 99.5%, for synthesis, 10 l, plastic packaging.

tert-Butyl (S)-(1-(3-aminophenyl)ethyl)carbamate, 95.0%, 250mg

N-(5-Chloro-2-fluorobenzyl)piperidin-4-amine dihydrochloride, 1g